Shares of Versigent (NYSE:VGNT – Get Free Report) have received an average rating of “Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $48.6667.
A number of equities analysts have commented on the stock. Zacks Research raised shares of Versigent from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 2nd. Wells Fargo & Company increased their price objective on shares of Versigent from $42.00 to $48.00 and gave the company an “overweight” rating in a research report on Thursday, June 25th. Morgan Stanley began coverage on shares of Versigent in a research note on Friday, May 8th. They set an “overweight” rating and a $51.00 target price for the company. Wolfe Research started coverage on shares of Versigent in a report on Thursday, April 30th. They set an “outperform” rating and a $53.00 target price for the company. Finally, Fox Advisors upgraded shares of Versigent to a “strong-buy” rating in a research note on Tuesday, April 7th.
View Our Latest Stock Analysis on Versigent
Versigent Trading Up 1.1%
See Also
- Five stocks we like better than Versigent
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
